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5The Administrator,
Deputy Vice Chancellor, Academic and Research,
Deputy Vice Chancellor, Planning, Quality Assurance and Development,
Registrar,
- Executive Deans of Faculties,
  Director: Research Development,
  Director: Postgraduate Studies,
  Heads of departments,
  Members of the University Community and Colleagues,
- Distinguished Guests,
   Ladies and Gentlemen,
   Friends,
   Students and Comrades,
I am pleased to stand here before you this afternoon to deliver this Professorial Inaugural Lecture 
on behalf of the faculty of Health Sciences. The word “Physician” is not mentioned in the book of 
wisdom, the Bible. Neither the word Physician nor the word Doctor “doctus” “IATROS”, is used in 
the Bible. This process will NOT be perceptible to the five senses, nor will it be understood by those 
who are not spiritual. It will not be perceptible nor understood by doctors, scientists, philosophers, 
scholars and religious leaders.
In the Holy Bible, Jeremiah 8:22 says: “Is there no balm in Gilead? Is there no physician there? 
Why then is there no healing of my people? In a rather humorous vein, one may ask: Is there no 
medicine in poor Eastern Cape Province of South Africa? Is there no physician there? Why then poor 
health among the sons and daughters of this province?
Daniel 1:4 talks about “young men in whom was no blemish, but handsome, and skilful in all wisdom 
and gifted in knowledge and understanding science and such as had ability in them to stand in the 
king’s palace and whom they might teach the learning and the language of the Chaldeans.”
I do stand to present strategic mandate, Vision, Mission and Core values of WSU through the 
present Professorial Inaugural Lecture. In this lecture, I attempt to converse in a broad sense about 
physiology, pathophysiology, mathematics, physics, molecular biology, cardiology, epidemiology and 
ecology.
I became an orphan at age 3 when my father died. He was an assistant physician during the Belgian 
colonial era in Congo.
I was born in Congo, which was under the Belgian colonization till 1960.
I take this time to thank the WSU management for appointing me as Research Champion Professor 
in order to reinvigorate research since 2009.
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7INTRODUCTION
I embrace all the scientific, clinical and public health publications that address “Cardiovascular Disease 
(CVD) and Metabolic Syndrome in Health Transition and Evidence-based Medicine: a perspective 
from Africa”.
The CVD pandemic worldwide presents a true challenge today with a high health burden that is 
only expected to rise. I address the causes and prevention of CVD, as well as CVD rehabilitation and 
physiology. As a member of the American Heart Association and European Society of cardiology, I 
practice under the level of evidence and the strength of recommendation of particular treatment 
options, as outlined in the tables below.
Classes of recommendations
Class I Evidence and/ or general agreement that a given treatment is 
beneficial
Class II Conflicting evidence and / or a divergence of opinion about the 
efficacy of the treatment
Class III Evidence or general agreement that the given treatment is not 
useful
Level of evidence
Level of evidence A Data derived from multiple randomized clinical trials or Meta-
analyses
Level of evidence B Data derived from a single randomized clinical trials or large non-
randomized studies
Level of evidence C Consensus of opinion of the expert and/of small studies, 
retrospective studies registries
Organization of the Inaugural Lecture
This lecture consists of the definitions, the aims, the Data sources, the data selection, the Data 
extraction and synthesis and the conclusion.
DEFINITIONS
CVD includes diseases such as atherosclerotic, particularly coronary heart disease (heart attack, 
heart failure, angina), stroke (brain attack, cerebrovascular accident when the blood flow to the 
brain is interrupted by blood clot), and peripheral artery.
8The life-long impact of heart and other chronic diseases and their traditional risk 
factors.
PREVENTION
WHOLE 
POPULATION
PREVENTION
WHOLE POPULATION
DIAGNOSIS, COST-EFFECTIVE 
MANAGEMENT
before birth
Genes•	
In the womb•	
Environment
Poverty•	
Cultural Factors•	
Political Factors•	
Urbanization•	
Climate  •	
change
Unhealthy  lifestyle
Unhealthy diet•	
Tobacco use•	
Excessive alcohol•	
Physical inactivity•	
Stress •	
Modifiable risk factors
Obesity•	
Hypertension•	
Tobacco addition•	
Diabetes•	
High blood •	
cholesterol legs 
other fats
Morbidity 
And 
Mortality
Blood vessels
Heart
Brain  
Kidneys
Lungs
Eyes
The new risk factors and biomarkers of CDV are now emerging through structural and biochemical 
parameters:
Low birth weight < 2500g;•	
Inflammation: fibrinogen•	
Infection: HIV, Helicobacter pylori;•	
Metabolic syndrome/ Insulin resistance;•	
Uric acid;•	
renal disease;•	
stress•	
oxidative stress/ antioxidant.•	
The metabolic syndrome is characterized by a clustering of CVD, metabolic, inflammatory and 
haemostatic risk factors.
The scope of the problem: past, present and future.
Africa is caught in the middle of disruptive epidemiologic, demographic, economic and nutritional 
transitions (Health transition). In contrast to the decrease in industrialized countries of non 
communicable diseases (NCD) such as CVD, there is a surprising rise in the morbidity and the 
mortality of CVD in Africa.
Our knowledge of the disease burden components of Africa populations was fragmentary in 
the past. Historically, the communicable diseases (CD with infectious and perinatal issues) have 
been emphasized. But, as some populations have undergone socio-economic, political changes 
(independences, end of apartheid), vital statistics have described a change in the pattern of disease. 
The picture is of a decline in infectious diseases and an increase in CVD with hypertension, diabetes 
mellitus and renal failure.
9ObJECTIVE 
I focus today on the emergence of CVD, and the metabolic syndrome as the paradigmatic example. 
Consequently, the lecture aims at providing the prevalence, the incidence, the risk factors, the 
predictors, the paradoxes, and the prevention of CVD.
DATA SOURCES
The criticism of Literature review was obtained through PubMed, PMC, Schoolar google, Honours, 
MSc, PhD, Proceedings and monographs search.
Published articles, Posters and abstracts from national, regional and international conferences were 
reviewed. The abstracts and complete articles relevant to the Professorial Inaugural Lecture were 
selected, read and analyzed to extract information.
The previous WSU Inaugural Lecture series helped me to consolidate my multidisciplinary and 
interdisciplinary Pedagogy with Problem-based Learning.
METHODS 
Despite the official new approach touting improvement in health indicators, current trends jeopardize 
population health, and hospital and population based surveys in Africa were related to methods with 
previous moderate and recent high levels of Evidence-based Medicine.
Inclusion criteria ensured that results maximized relevance, validity, and reliability while producing 
comparable in developed nations, emerging economic nations and African countries.
The World Health Organization (WHO) STEPwise approach to chronic disease risk factors surveillance 
helped me to use structured and standardized methods with comparable valid data worldwide for 
prevention of basis, objectives of surveillance, risk factor definition, major behavioural factors and 
rationale for inclusion of core risk factor.
The following diagrams illustrate the general concept of the Stepwise approach.
Risk factors surveillance. 
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Stroke surveillance.
Global school-based student health survey.
RESULTS
Extensive findings are presented below.
The metabolic syndrome in Africa 
Contrary to the past, metabolic syndrome is no longer rare in Africa. The prevalence is increasing, 
and it tends to increase with age.
HIV/AIDS
Prevalence of metabolic syndrome by NCEP criteria was 26.6%. 15.7% and 21.9% for HIV on ART, 
ART naïve HIV and HIV negative individuals, respectively.
Exposure to ART in HIV-patients and metabolic syndrome are the independent risk factor of Insulin 
resistance.
Incidence of diabetes mellitus among HIV-patients
CVD and HIV/AIDS
Risk factors among school children
Risk factors in workplace
CVD, metabolic syndrome and helicobacter pylori
Metabolic syndrome, pulse pressure, hypertension, nutrition, oxidative stress and diabetic ocular 
diseases
Seasons, climate and CVD
Hypertension: genetic pattern for Africans
Epidemic of diabetes mellitus
Vegetables intake and pre-eclampsia
Lipids, Atherosclerosis and Sickle Cell Disease
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Fruit and vegetables consumption in the population and by sex.
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Overweight and obesity in the whole population and by sex. 
 
 
 
 
 
Increase of detected HTA rate with age in the whole population, men and 
women. 
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Weak risk and high risk in the population. 
 
 
 
 
 
 
   Waist measurement group (cm) 
% detected HTA 
15
Increase of detected HTA rate with age in the whole population, men and women.
 
Weak risk and high risk in the population.
   Waist measurement group (cm)
% detected HTA
Positive relation between detected HTA rate and bMI groups.
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Distribution of participants with low birth weight by the year of birth (P for 
trend=<0.0001) and economic growth (GNP) in % for Congo between 1930 
and 1955.Current characteristics of 407 participants categorized by level of 
their birth weight. 
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Means of continuous variables of 407 participants categorized by the 
presence of metabolic syndrome (Mets) defined according to WHO criteria. 
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Relationship between the prevalence of the metabolic syndrome defined to 
WHO criteria and the levels of fasting plasma glucose in 407 patients. P for 
trend<0.0001. 
 
Multivariate regression analysis for factors potentially linked to the presence 
of the metabolic syndrome defined to WHO criteria among 407 patients. 
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Relationship between prevalence of the metabolic syndrome according to 
WHO criteria among 407 patients. P for trend=0.007. 
 
 
 
 
Relationship between prevalence of the metabolic syndrome according to 
WHO criteria among 168 women. 
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Relationship between the prevalence of metabolic syndrome (Mets) and 
nutritional status categories in all patients (     ) , men (     ) and women (     ). 
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Means and standard deviation for selected characteristics of all non 
hypertensive, prehypertensive and normotensive participants. 
 
 
 
 
Factor loadings for original variables with rotated factors in normotensive 
employees. 
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Factor loadings for original variables with rotated factors in prehypertensive 
employees. 
 
 
 
 
 
 
 
Relationship between the prevalence of prehypertention and ages of non 
hypertensive bank employees. 
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Respective risk of prehypertension conferred by overweight/total obesity, 
abdominal obesity and age >=35 years. 
 
Causes of Death- Global. 
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Deaths by cause in South Africa. 
 
 
 
/ /
25% of adult population
Malignant hypertension: 16% of hospital admissions
3636 ESRF patients in SADTR / 6 years 
Essential HPT: 15.9% of ESRF- 57% with malignant change
Age group for malignant HPT (30-39 years): 37.4%
Veriava J. Human Hypertens. 1990
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Hypertension as a cause of ESRD in South Africa. 
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The global burden of diabetes (2000-2030). 
 
 
 
 
 
 
The world health is in transition. 
 
World Health Organization
3rd Global Forum on NCD Prevention and Control,
Rio de Janeiro, 9-12 November 2003
Epidemiological: NCD overriding CD, & double
burden of diseases in many
developing countries
Demographic: Population ageing
Lifestyles: Diets are rapidly changing 
Physical activity reducing
Tobacco use increasing
Urbanization: Growing cities
Globalisation: Increasing global influences
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Map of Eastern Cape Province in South Africa with districts. 
 
 
 
 
 
Mayosi et al. Lancet 2009;374:934-947 
 
Death rate per 100 000 population from cardiovascular and related diseases 
in 15-64 year old male (A) and female (B) South Africans 1999-2006. 
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bP control at baseline.
Prevention
The usefulness of these and other data on CVD include planning for primordial, primary, secondary 
and tertiary prevention in Africa
Additional long term surveillance data to define the burden and distribution of etiologies are necessary 
in Africa. Education and advocacy to transfer the present results to policymakers, Administrator and 
Community of WSU, researchers, and population is required.
Africa can overcome its slow response to the CVD epidemic and curb further deterioration by reducing 
metabolic syndrome (obesity as the perquisites) and, thus, inheritance and clustering of risk factors. 
This can be achieved via multilayered awareness and intensive parental and familial involvement.
41
CONCLUSION
Honorable Administrator, I hope that I attempted to present perspectives for the future. As a species, 
we have ventured well beyond our evolutionary Africa, and the burden of CVD imposed by these 
environmentally mediated anomalies in our society are the principal challenges for Prevention.
Reasoning in the opposite direction, it is clear that some CVD allows an evolutionary solution while 
others do not.
Our results and other African research are significantly associated with the emergence of CVD
Among these risk factors, aging, female sex, inappropriate diet, physical inactivity, obesity, HIV 
infection, smoking, excessive alcohol intake, Helicobacter pylori infection, inflammation, imbalance 
of oxidative stress, seasons/climate change, malnutrition and low birth weight are suggested as 
causes of CVD.
Unfortunately, no similar solutions exist for obesity, hypertension and diabetes mellitus. On average, 
we are programmed from fetal life to adult hood as a species to experience an increase in body 
weight, blood pressure and blood gloose with age under the conditions of Coca colonization due to 
modern and Western life.
In this perspective the challenges of CVD in Africa are no different from any other modernized 
segments of the world of races, but of one Human race with ethnic groups.
While the general biological principles may be surely the same, the social conditions under which 
they are operating are different. African modifications of preventive strategies will be necessary.
Long-term, Africa-based surveillance projects are needed to define the burden of CVD-both the 
morbidity and the mortality.
Availability of new tools, including molecular biology, will provide important resources for African 
researchers in areas from epidemiological approaches and diagnostics to etiological research.
The increase in CVD and its impact has gained paid attention in recent years. Theories of developmental 
and degenerative determinants of CVD are discussed to provide strong evidence for a causally 
informed approach to prevention.
Finally, in a renewed research environment of WSU, a developmental University, technological, 
scientific, innovative and responsive, as the essential long-term goal of my Professorial Inaugural 
Lecture integrated research on human biology must be successful if we are to construct either 
evolutionary or non-evolutionary preventive strategies. 
GOD BLESS WITH LOVE
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1998, presented two theses on cardiovascular diseases in HIV-patients and in rheumatic heart 
diseases among children. He was awarded the degree of DSc in Cardiovascular Sciences.
Dr Longo-Mbenza’s professional working life started as a lecturer from 1981, till 2007 rising through 
Senior Lecturer, Associate Professor, Full Professor and Outstanding Professor of Medicine at the 
University of Kinshasa, DR Congo. He served at the University of Kinshasa as Dean of the Faculty of 
Medicine, the deputy Vice Chancellor, Academic Affairs and the Vice Chancellor.
At the University of Kinshasa, Professor Longo-Mbenza taught general Human Physiology, Anatomy 
Physiology, Cardiolovascular Physiology, Pathophysiology, renal Physiology, Cardiology, Rehabilitation 
and Hematology.
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In 1980, Professor Longo-Mbenza detected symptoms of Immunodepression among Congolese 
patients with chronic diarrhea when later Ugandan colleagues spoke about Slim Disease with 
Trypanosoma, and US CDC discovered AIDS in 1981. Because of the merit of Professor Longo-
Mbenza who was awarded a Fulbright Scholarship, he worked in 1985 as a Visiting Professor in 
Clinical Pharmacology, Hypertension and Lipids at Baylor College of Medicine, Houston, Texas, USA. 
He worked on Beta-receptors research.
Professor Longo-Mbenza served as a consultant to the World Health Organization and the United 
Nations for Climate Change. He is a member of New york Academy of Sciences, the American 
Heart Association, the Belgium Cardiac Society, the French Cardiac Society, the Egyptian Cardiac 
Society, the Congolese cardiac Society, the Pan African Society of Cardiology, the Human Genome 
Organization, the International Society on Hypertension in Blacks, the American Society of Blacks 
cardiologists, the International Hypertension Society and other scientific societies.
Professor Longo-Mbenza’s original and prolific research, and accomplished clinical practice were 
focused on elucidating the pathophysiological mechanisms of toxic myocarditis and immune-allergic 
cardiomyopathies.
From 1980s until present, most of his research works are related to molecular biology in intestinal 
parasites in HIV/AIDS, inflammatory states, oxidative stress, genetics, biomarkers and environmental 
impacts in atherosclerosis, Geophagia, Sickle Cell Disease, HIV/AIDS-related cardiac lesions, diabetes 
mellitus, and co-expression of genes in pancreas.
In addition to his role as clinician, lecturer and academic leader, Professor Longo-Mbenza has been 
a very productive scientist: Editorial-Board member of more than 30 International Journals such as 
Stroke, supervisor of more than 10 PhD theses, 25 MSc theses, 100 mini-dissertations, 6 books, and 
over 300 papers published in Romanian, Spanish, French, and English languages.
Professor Longo-Mbenza speaks 11 languages and participated in more than 50 international 
conferences and travel studies on all the continents. He is currently a Research Professor at the 
Faculty of Health sciences, Walter Sisulu University, Mthatha, South Africa.
With his valuable input, he will learn more about that he thinks. 
In the future, Professor Longo-Mbenza will continue to expand his sphere of collaboration with 
researchers in various disciplines in order to enhance the profile of WSU.
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